Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Derisomaltose for Pre-operative Iron-deficiency Anemia in Gynecologic Oncology Surgery
NCT05407987Phase 3Recruiting
- Sponsor
- American Health Staffing Group
- Start
- Apr 2025
- Primary completion
- Dec 2027
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by American Health Staffing Group. Started Apr 2025; status: recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05407987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05407987.